Hepatitis C virus NS3 proteinase (NS3 protease)

Hepatitis C virus NS3 proteinase is a viral serine protease located in the N-terminal region of the nonstructural protein 3 (NS3) of HCV, working as a proteolytic enzyme responsible for cleaving the viral polyprotein at multiple sites to produce mature, functional nonstructural proteins essential for virus replication. NS3 forms a stable complex with its cofactor, NS4A, which activates the enzyme and is required for full protease activity. The NS3/4A protease also disrupts host innate immunity by interfering with antiviral signaling pathways, making it a critical target for direct-acting antivirals in hepatitis C therapy. Several protease inhibitors targeting NS3/4A have been clinically approved, significantly improving HCV treatment outcomes, though resistance emerges rapidly due to the virus’s high mutation rate. The protease domain displays a chymotrypsin-like fold, harboring a catalytic triad essential for activity and a shallow substrate binding site that creates challenges for drug design. NS3 protein also contains a C-terminal helicase domain, but inhibitors currently in use clinically target the protease portion.

Other names

HCV NS3 proteaseHepatitis C virus NS3 serine proteaseNS3/4A protease (when complexed with NS4A, its activating cofactor)

Competitive inhibition of the active site (most drugs mimic substrate or bind to the catalytic site, preventing cleavage of the viral polyprotein); Allosteric inhibition (newer drug classes target sites affecting NS4A binding or involved in protein folding); Trap inactive conformations by exploiting zinc-dependent folding